(1 - 15 von 23
)
FDA Grants Orphan Drug Designation to Debiopharm ...Europa Press
www.europapress.es
— ... Peggy Lipp, Director, Regulatory Affairs, Business Intelligence & Market Access, Debiopharm International S.A. "It speaks to the need for — ... Peggy Lipp, Director, Regulatory Affairs, Business Intelligence & Market Access, Debiopharm International S.A. "It speaks to the need for ...
EMA Grants Orphan Drug Designation to Debiopharm ...Libero Quotidiano
www.liberoquotidiano.it
... Peggy Lipp, Director, Regulatory Affairs, Business Intelligence & Market Access, Debiopharm International S.A. "It speaks to the need for new treatment Peggy Lipp, Director, Regulatory Affairs, Business Intelligence & Market Access, Debiopharm International S.A. "It speaks to the need for new treatment ...
FDA Grants Fast Track Designation to Debio The ASCO Post
ascopost.com
— ... Peggy Lipp, Director, Regulatory Affairs, Market Intelligence & Market Access, Debiopharm International. “It is critical that we address the — ... Peggy Lipp, Director, Regulatory Affairs, Market Intelligence & Market Access, Debiopharm International. “It is critical that we address the ...
FDA Grants Fast Track Designation to Debiopharm ...PR Newswire UK
www.prnewswire.co.uk
— " said Peggy Lipp, Director, Regulatory Affairs, Market Intelligence & Market Access at Debiopharm International. "It is critical that we — " said Peggy Lipp, Director, Regulatory Affairs, Market Intelligence & Market Access at Debiopharm International. "It is critical that we ...
sortiert nach Relevanz / Datum